Destiny Pharma (DEST) Releases Quarterly Earnings Results, Beats Expectations By $4.30 EPS
10 Apr 2019
Modern Readers
Destiny Pharma (LON:DEST) announced its quarterly earnings results on Tuesday. The company reported GBX (11.90) (($0.16)) EPS for the quarter, beating the Zacks' consensus estimate of GBX (16.20) (($0.21)) by GBX 4.30 ($0.06), Digital Look Earnings .